Thomas Stephan
Stock Analyst at Stifel
(2.19)
# 2,697
Out of 4,732 analysts
37
Total ratings
44%
Success rate
-1.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Hold | $40 → $35 | $30.39 | +15.17% | 8 | Jan 13, 2025 | |
| GKOS Glaukos | Maintains: Buy | $153 → $175 | $156.39 | +11.90% | 8 | Dec 31, 2024 | |
| BLCO Bausch + Lomb | Maintains: Hold | $16 → $19 | $17.36 | +9.45% | 2 | Sep 23, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $50 → $44 | $22.29 | +97.40% | 8 | Aug 26, 2024 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.66 | +20.48% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $84.37 | +18.53% | 4 | May 15, 2024 | |
| SGHT Sight Sciences | Maintains: Buy | $6 → $7 | $2.83 | +147.35% | 5 | Mar 8, 2024 |
RxSight
Jan 13, 2025
Maintains: Hold
Price Target: $40 → $35
Current: $30.39
Upside: +15.17%
Glaukos
Dec 31, 2024
Maintains: Buy
Price Target: $153 → $175
Current: $156.39
Upside: +11.90%
Bausch + Lomb
Sep 23, 2024
Maintains: Hold
Price Target: $16 → $19
Current: $17.36
Upside: +9.45%
STAAR Surgical Company
Aug 26, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $22.29
Upside: +97.40%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.66
Upside: +20.48%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $84.37
Upside: +18.53%
Sight Sciences
Mar 8, 2024
Maintains: Buy
Price Target: $6 → $7
Current: $2.83
Upside: +147.35%